Foster City, CA, United States of America

Heng Cheng

USPTO Granted Patents = 17 (Patent Applications = 2)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 2)

Average Co-Inventor Count = 3.8

ph-index = 7

Forward Citations = 183(Granted Patents)

Location History:

Millbrae, CA (US) (2014 - 2015)
Foster City, CA (US) (2010 - 2018)
Fremont, CA (US) (2019 - 2020)

Company Filing History:

7 out of 3,684

Bristol-myers Squibb Compnay

E. R. Squibb Sons, Inc.

patents

Years Active: 2010-2020

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10869934 - Antiproliferative compounds and conjugates made therefrom (2020-12-22),

2. 10398783 - Antiproliferative compounds and conjugates made therefrom (2019-09-03),

3. 10077287 - Tubulysin analogs and methods of making and use (2018-09-18),

4. 9688721 - Tubulysin compounds, methods of making and use (2017-06-27),

5. 9580467 - Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof (2017-02-28),

6. 9382289 - Tubulysin compounds, methods of making and use (2016-07-05),

7. 9226974 - Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof (2016-01-05),

8. 9109008 - Tubulysin compounds, methods of making and use (2015-08-18),

9. 9000006 - Thienopyridine compounds, and methods of use thereof (2015-04-07),

10. 8980824 - Tubulysin compounds, methods of making and use (2015-03-17),

11. 8802632 - Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof (2014-08-12),

12. 8772543 - Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof (2014-07-08),

13. 8772542 - Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof (2014-07-08),

14. 8703795 - Thienopyridine compounds, and methods of use thereof (2014-04-22),

15. 8394922 - Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof (2013-03-12),

Title: **Heng Cheng: Pioneering Anticancer Innovations**

Introduction

Heng Cheng is an accomplished inventor based in Foster City, CA, with an impressive portfolio of 17 patents. Throughout his career, he has made significant contributions to the field of biomedical research, particularly in the development of compounds used in cancer treatment.

Latest Patents

Heng Cheng’s latest patents focus on antiproliferative compounds and conjugates made therefrom. These innovative compounds are capable of inhibiting cell proliferation, providing valuable therapeutic options for cancer treatment. Specifically, these compounds possess a structure according to a defined formula, making them especially useful as anti-cancer agents, particularly in the form of antibody-drug conjugates.

Career Highlights

Heng Cheng has held prominent positions in leading biotech companies, including Bristol-Myers Squibb Company and Fibrogen, Inc. His work has significantly impacted cancer research and treatment, showcasing his dedication to advancing medical science through innovative solutions.

Collaborations

Throughout his career, Heng has collaborated with notable colleagues, including Sanjeev Gangwar and Qiang Cong. These partnerships have fostered a creative environment that has led to the successful development of several groundbreaking therapies.

Conclusion

In summary, Heng Cheng is a notable inventor whose efforts in developing antiproliferative compounds reflect his commitment to combatting cancer. His extensive patent portfolio and collaborations with distinguished professionals highlight his role as a key player in the field of medical innovation.

This text is generated by artificial intelligence and may not be accurate.